Recurrent Verrucous Carcinoma of the Larynx Recruiting Phase 1 Trials for Hydroxyurea (DB01005)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01847326Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerTreatment